Review of cariprazine in management of psychiatric illness.

@article{Campbell2017ReviewOC,
  title={Review of cariprazine in management of psychiatric illness.},
  author={Rebecca H Campbell and Michael Diduch and Kristen N Gardner and Christopher J Thomas},
  journal={The mental health clinician},
  year={2017},
  volume={7 5},
  pages={
          221-229
        }
}
Schizophrenia and bipolar disorder are severe and debilitating psychiatric disorders. Despite the availability of numerous antipsychotic drugs, many patients still experience poor outcomes and treatment-limiting adverse side effects. Cariprazine is a novel antipsychotic with unique pharmacodynamic and pharmacokinetic properties. It is both a dopamine type 2 and dopamine type 3 partial agonist with 2 equipotent metabolites, desmethyl cariprazine and didesmethyl cariprazine, of which didesmethyl… CONTINUE READING
BETA

From This Paper

Topics from this paper.

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…